Idle thoughts of a 'well-calibrated' Bayesian in clinical drug development.

about

Response-adaptive clinical trials: case studies in the medical literature.Bayesian Phase II optimization for time-to-event data based on historical information.Personalized Medicine Enrichment Design for DHA Supplementation Clinical Trial.

P2860

Q39300281-035669F2-F7F5-4109-AC64-C2E71505D536 Q47238385-860BEC1F-CEEC-4731-A5F2-E6EE18847E41 Q53784044-B68A1DA5-DF94-490E-A168-C5306CA7331A

P2860

Idle thoughts of a 'well-calibrated' Bayesian in clinical drug development.

Item

http://www.wikidata.org/entity/Q38707747

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Idle thoughts of a 'well-calibrated' Bayesian in clinical drug development.

@en

type

Item

label

Idle thoughts of a 'well-calibrated' Bayesian in clinical drug development.

@en

prefLabel

Idle thoughts of a 'well-calibrated' Bayesian in clinical drug development.

@en

P1476

Idle thoughts of a 'well-calibrated' Bayesian in clinical drug development

@en

P2093

Andrew P Grieve

http://www.w3.org/2001/XMLSchema#string

P2860

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

A multiple testing procedure for clinical trials

Interim analyses for randomized clinical trials: the group sequential approach

The CARE guidelines: consensus-based clinical case reporting guideline development

Summarizing historical information on controls in clinical trials

Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

Use of historical control data for assessing treatment effects in clinical trials.

Where's the utility in Bayesian data-monitoring of clinical trials?

P304

96-108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PST.1736

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrew P Grieve

P577

2016-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26799060

http://www.w3.org/2001/XMLSchema#string

Idle thoughts of a 'well-calibrated' Bayesian in clinical drug development.

about

P2860

P2860

Idle thoughts of a 'well-calibrated' Bayesian in clinical drug development.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698